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a  b  s  t  r  a  c  t
The  aims  of the  present  study  were  to investigate  whether  exercise  can  improve  the  depression-like
behavior  caused  by  estrogen  deﬁciency.  Given  that  decreased  level  of brain-derived  neurotrophic  factor
(BDNF)  in  many  brain  areas including  hippocampus  and  prefrontal  cortex  is associated  with  estrogen
deﬁciency-induced  depression-like  behavior,  we  also  determined  whether  exercise  affects  the  levels  of
BDNF  and its  receptor  in  hippocampus  and prefrontal  cortex  (PFC).  It was  found  that ovariectomy  (OVX)
caused  an  increase  in depression-like  behavior  in rats  and  a decrease  in BDNF  level  in hippocampus  but
not in  PFC.  The  expression  of  TrkB,  a high  afﬁnity  BDNF  receptor  in  hippocampus  and  PFC was  not  affected
by  OVX.  17-estradiol  (E2) treatment  ameliorated  depression-like  behavior  and  increased  BDNF  level  in
hippocampus  in OVX  rats. Serum  E2 level  inversely  correlated  to  depression-like  behavior  and  positivelystrogen
epression
correlated  to BDNF  level  in hippocampus.  Exercise  ameliorated  depression-like  behavior,  increased  serum
E2 level  and  BDNF  level  in hippocampus  in  OVX  rats. The  increased  E2 level  did  not correlate  to BDNF level
but  correlated  with  some  of  the  behaviors  in  the  rats  subjected  to  exercise.  Our  results  suggested  that  E2
maintains  BDNF  in  hippocampus,  thereby  ameliorating  depression-like  behavior.  Exercise  amelioration
of  depression-like  behavior  in OVX  rats  is  partly  due  to increased  serum  E2 level.
©  2014  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC. Introduction
Depression is a signiﬁcant public health problem due to both
ts high prevalence and its devastating impact on individuals and
ociety. It was found that ovarian hormones, particularly estro-
ens, have profound effect on incidence and/or symptomology of
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depression [1]. Menopausal declines in circulating estrogen lev-
els are associated with increased susceptibility to develop major
depressive disorder (MDD) [2]. Rodents have also shown an
increase in depression-like behavior during the diestrus phase of
the estrous cycle when the levels of estrogens are low [1]. Ovariec-
tomy (OVX), which removes the primary source of estrogens, elicits
depression-like behavior in rats [3].
Several reports have indicated that estrogen replacement ther-
apy can produce antidepressant effects in both clinical and
pre-clinical studies [3,4]. Given that estrogen therapy results in
some severe side effects including thrombotic events, breast cancer
and dementia [5], there is obvious interest in developing better and
safer therapeutic approaches. Increasing evidence suggests that
exercise may  play a protective role in mood disorders [6]. Clini-
cal data has shown that physical exercise can reduce depressive
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ymptoms and prevent depression relapse [6]. Animal studies have
lso suggested exercise amelioration of depression-like behavior
7]. Our previous study has demonstrated that swimming exer-
ise reduces depressive behavior in two rat models of depression
8,9]. However, there are few studies about the effect of exercise on
epression-like behavior caused by estrogen deﬁciency.
Exercise can modulate some neurotransmitters and neu-
otrophin expression in clinical and rodent studies [10,11]. Changed
xpression of neurotrophic factors, such as brain-derived neu-
otrophic factor (BDNF), is associated with depression in both
umans and animal models [12]. The levels of BDNF and its
eceptor were decreased in hippocampus of MDD  patients [13].
tudies in rodents have indicated that decreased BDNF level
n many brain regions is associated with the development of
epression-like behavior in OVX rats [3]. Administration of BDNF
nto the hippocampus of depressive animal model ameliorates
he behavioral changes as antidepressant treatment does [14].
n the present study, we therefore investigated the effect of
VX on depression-like behavior and the levels of BDNF and its
igh-afﬁnity tropomyosin-related kinase B (TrkB) receptor in hip-
ocampus and prefrontal cortex (PFC) in female rats, and then
etermined whether exercise alleviates the depression-like behav-
or induced by this paradigm and the expression of BDNF and TrkB.
ur study would extend the knowledge of the mechanisms under-
ying exercise amelioration of depression.
. Materials and methods
.1. Animals
A total of 56 adult female Sprague–Dawley rats (Shanghai SLAC
aboratory Animal Co.), weighing 200 ± 20 g, were housed with reg-
lar light-dark cycles under controlled temperature (22 ± 2 ◦C) and
umidity (50 ± 10%), and were given standard diet and water ad
ibitum. All animal protocols were approved by the Ethical Commit-
ee of Experimental Animals of Second Military Medical University
nd Shanghai University of Sport.
.2. Groups, surgical procedure and exercise training
We  ﬁrstly used 24 rats which were randomly assigned to
ham, OVX and OVX-E2 groups (n = 8 for each group) to exam-
ne the depression-like behavior and the levels of BDNF and TrkB.
ham operation or bilateral OVX was performed under anesthe-
ia with sodium pentobarbital (60 mg/kg, i.p.). After recovery for 1
eek, OVX rats were divided into two groups OVX-E2 and OVX
roups. OVX-E2 rats were subcutaneously administered with E2
Sigma–Aldrich, St Louis, MO)  (dissolved in 0.1 ml  sesame oil) at
 dose of 30 g/kg/day for 8 weeks. OVX rats were administered
ith 0.1 ml  sesame oil as placebo for 8 weeks.
To determine the effects of exercise on depression-like behav-
or, we set up another independent experiment using 32 rats
hich were randomly assigned to Sham-sedentary (Sham),
ham-exercise (Sham-Ex) groups, OVX-sedentary (OVX) and OVX-
xercise (OVX-Ex) groups (n = 8 for each group). One week after
VX operation, rats were adapted to the treadmill for 1 week
15 min/day at 15 m/min  on a 0% slope) and then gradual increase
n running time and speed to 60 min/day at 18 m/min on a 0% slope,
 days/week for the next 7 weeks (supplement Fig. S1).
.3. Behavioral testsRats were examined by behavioral tests after 8-week E2 treat-
ent or exercise. Open ﬁeld test (OFT) and tail suspension test (TST)
ere performed as described previously [7,15] at 14:00 p.m. to
7:00 p.m. In OFT, each rat was placed at the center of the openers 573 (2014) 13–18
ﬁeld (60 × 60 × 60 cm chamber) for 5 min. A video-computerized
tracking system was  used to record the behavior of the animals.
Parameters assessed were total distance (meters), number of cross-
ing squares and immobile episodes. In TST, each rat was suspended
by the tail with bands and hung from a mounted hook. The duration
of immobility during the total 6 min  was measured. Immobile time
was deﬁned as a lack of all movement except for whisker movement
and respiration.
2.4. Blood and tissue sample collection
Rats were decapitated at 12:00 p.m. to 13:00 p.m. Sham rats
were sacriﬁced at the diestrus phase. Trunk blood was collected.
Simultaneously, hippocampus and PFC were rapidly separated as
described by O’Leary et al. [16]. Serum, hippocampus and PFC were
stored at −80 ◦C until assays.
2.5. Determination of E2 and BDNF
17-estradiol (E2) content in serum was assayed using radioim-
munoassay kit (Sino-UK Institute of Biological Technology, Beijing,
China), and BDNF levels in hippocampus and PFC were determined
using ELISA kit (R&D, Minneapolis, USA), following the manufac-
turer’s instructions.
2.6. Western blotting analysis
Tissues were homogenized in cold T-Per lysis buffer (Pierce
Biotechnology, USA). The protein concentration was determined
using a BCA protein Assay Kit (BioTeke, Beijing, China). The samples
were quickly soniﬁed in ice bath, boiled 5 min  at 95 ◦C. 50 g pro-
tein of each sample was  loaded and separated by 10% SDS–PAGE
and subsequently transferred to nitrocellulose membranes. The
membranes were then incubated with antibodies against TrkB
(Santa Cruz, CA) at a dilution 1:500 overnight at 4 ◦C. After washes,
the membrane was  incubated with the secondary antibodies
of horseradish peroxidase-conjugated antibody. Immunoreactive
proteins were detected using the enhanced chemiluminescence
Western blotting detection system (Santa Cruz, CA) and visual-
ized using Sygene Bio Image system and analyzed following by
GeneSnap and GeneTools software (Synoptics Ltd., UK).
2.7. Statistics
Data were presented as mean ± SEM. All data were tested for
homogeneity of variance by the Bartlett test at ﬁrst and then ana-
lyzed using one-way or two-way ANOVA followed by Dunnett’s
or LSD post hoc test. Pearson’s correlation analysis was used to
examine the relationship between E2 and BDNF level as well as
the parameters of behaviors. All statistics were carried out using
SPSS software version 16.0 (SPSS Inc., USA). P < 0.05 was  considered
signiﬁcant.
3. Results
3.1. The effects of OVX and E2 replacement on depression-like
behavior
OVX rats showed increased depression-like behavior including
decreased total distance (P < 0.01) and number of crossing squares
(P < 0.01) in OFT, and increased number of immobile episodes
(P < 0.01) in OFT and immobile time (P < 0.01) in TST compared to
Sham group. E2 replacement signiﬁcantly reduces depression-like
behavior in OVX rats (P < 0.01) (Fig. 1A–D).
The level of E2 in serum correlated to several behavioral indexes
including total distance (R2 = 0.717, P < 0.01), number of immobile
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Fig. 1. The effects of OVX and E2 replacement on depression-like behavior. Sham operation or bilateral OVX was performed, and then OVX rats were subcutaneously
administered with E2 (30 g/kg/day) or placebo for 8 weeks. Behavior was  determined using OFT and TST. Data shows total distance (meters) (A), the number of crossing
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aquares  (B) and immobile episodes (C) in OFT, the immobile time (D) in TST. The lev
as  performed to analyze the correlation between serum E2 levels and total distan
mmobility time (I) in TST. Data are presented as means ± SEM (n = 8 in each group)
pisodes (R2 = 0.523, P < 0.01) as well as immobility time (R2 = 0.542,
 < 0.01) (Fig. 1F–I). No signiﬁcant correlation was found between
2 level and the behavioral index, the number of crossing squares.
.2. The effects of OVX and E2 replacement on BDNF level and
rkB expression in hippocampus and PFC
Decreased BDNF and its receptor are involved in depression-like
ehavior [3]. Some brain areas, such as PFC and hippocampus, have
een known to be responsible for depression-like behavior [17].
s shown in Fig. 2, BDNF level in hippocampus was signiﬁcantly
ecreased in OVX rats compared to Sham rats (P < 0.01), which was
eversed by E2 treatment (P < 0.01). Moreover, BDNF level in hip-
ocampus correlated to serum E2 level (R2 = 0.304, P < 0.05). BDNF
evel in PFC was not signiﬁcantly differed among Sham, OVX and
VX-E2 groups.
There was no signiﬁcant difference in TrkB protein expression
n hippocampus and PFC among Sham, OVX and OVX-E2 groups.
.3. Exercise ameliorates depression-like behavior and increases
DNF level in hippocampus of OVX rats
Exercise ameliorated depression-like behavior in OVX rats,
ncluding increasing total distance (P < 0.01) and number of cross-
ng squares (P < 0.01) and decreasing number of immobile episodes
P < 0.01) and immobile time in TST (P < 0.05) (Fig. 3A–D). Exercise
id not affect the above behaviors in Sham rats.
Exercise could increase serum E2 level in OVX rats (P < 0.05)
Fig. 3E). E2 level correlated to total distance (R2 = 0.500, P < 0.05)
nd the number of immobile episodes (R2 = 0.273, P < 0.05), but did
ot correlate to the number of crossing squares and immobility
ime (Fig. 3F–I).
Exercise signiﬁcantly increased BDNF level in hippocampus but
ot in PFC in both Sham (P < 0.05) and OVX rats (P < 0.01) (Fig. 4A
nd B). BDNF level in hippocampus did not correlate to E2 level in
VX rats with or without exercise (Fig. 4C).
There was no signiﬁcant difference in TrkB protein expression
n hippocampus and PFC among the experimental groups (Fig. 4D
nd E).serum E2 was determined by radioimmunoassay (E). Pearson’s correlation analysis
eters) (F), number of crossing squares (G) and immobile episodes (H) in OFT, and
.05, **P < 0.01 vs. Sham, ##P < 0.01 vs. OVX. R: Pearson’s correlation coefﬁcient.
4. Discussion
The present study has demonstrated that OVX induced
depression-like behavior by showing decreased total distance and
number of crossing squares, as well as increased number of immo-
bile episodes in OFT and immobile time in TST in rats. Both E2
treatment and exercise ameliorated depression-like behavior in
OVX rats. OVX resulted in a decrease in BDNF level in hippocampus
but not in PFC, which can be restored by E2-replacement as well as
exercise.
OVX rats exhibit depression-like behavior and estrogen
treatment can decrease depression-like behavior or facilitate
antidepressant action [18]. The present study showed E2 treat-
ment ameliorated depression-like behavior including a decrease
in locomotor activity and behavioral despair in OVX and serum E2
level correlated to some parameters of depression-like behavior,
conﬁrming the antidepressant effect of E2.
Infusion of BDNF into brain or hippocampus has antidepressant-
like effects [14]. Many antidepressant drugs exert their effects
through modulation of BDNF expression in the hippocampus in
humans and animal models [12]. The present study showed that
OVX decreased BDNF expression in hippocampus while caused
depression-like behavior, which was  restored by E2 replacement.
E2 level positively correlated to BDNF level in hippocampus. These
data are consistent with previous studies that estrogen replace-
ment increases BDNF expression in many brain regions including
hippocampus in OVX rats [3]. Activation of TrkB has been impli-
cated to play a role in antidepressant action [19]. We  found that
OVX and E2 replacement did not affected TrkB protein expression
in hippocampus and PFC. However, whether E2 affect the level of
phosphorylated TrkB remains to be elucidated.
Several brain regions including the PFC, amygdala, and
hippocampus have been implicated in mood disorders [17]. Hip-
pocampus has been considered as an important component of the
limbic system and the target of estrogens [1,20]. It has been shown
that E2 is concentrated in hippocampus after administration of E2
into female rats [1,21]. Our data that OVX and E2 replacement
caused changed BDNF level in hippocampus support that hip-
pocampus is a putative focal area for estrogens. In the present study,
it is hard to explain why  estrogen has no effect on BDNF in PFC. Clas-
sically estrogen binding to estrogen receptors (ERs) enhances the
16 J. Lu et al. / Neuroscience Letters 573 (2014) 13–18
Fig. 2. The effects of OVX and E2 replacement on BDNF level and TrkB expression in hippocampus and PFC. Sham operation or bilateral OVX was performed, and then OVX
rats  were subcutaneously administered with E2 (30 g/kg/day) or placebo for 8 weeks. The hippocampus and PFC of rats were collected for determination of BDNF level and
T  level 










#rkB  expression as described in Section 2. A, BDNF level in hippocampus; B, BDNF
etween serum E2 levels and BDNF level in hippocampus. D, TrkB protein expressio
resented on top of histogram. All data are presented as means ± SEM (n = 8 in eachbility of receptors to bind to estrogen response elements (EREs) in
he promoter many, though not all, estrogen-response genes [22].
nce at the promoter, estrogen-bound ER, interacts with coregu-
ator proteins to form a multiprotein complex that modulates the
ig. 3. The effects of exercise on depression-like behavior. Sham operation or bilateral OV
ST.  Data shows total distance (meters) (A), the number of crossing (B) and immobile epis
y  radioimmunoassay (E). Pearson’s correlation analysis was performed to analyze the cor
quares (G) and immobile episodes (H) in OFT, and immobility time (I) in TST. Data are pre
#P < 0.01 vs. OVX. R: Pearson’s correlation coefﬁcient.in PFC. C, Pearson’s correlation analysis was performed to analyze the correlation
ippocampus; E, TrkB protein expression in PFC. Representative protein bands were
p). **P < 0.01 vs. Sham, ##P < 0.01 vs. OVX. R: Pearson’s correlation coefﬁcient.expression of target genes [23]. It is known that the differences
in subtype of ERs and the coregulator proteins are responsible
for the tissue-speciﬁc effects of estrogen. Both of ER and ER
have been identiﬁed in hippocampus and PFC [1,24]. However,
X was performed. After 8 weeks exercise, behavior was determined using OFT and
odes (C) in OFT, the immobile time (D) in TST. The level of serum E2 was  determined
relation between serum E2 levels and total distance (meters) (F), number of crossing
sented as means ± SEM (n = 8 in each group). *P < 0.05, **P < 0.01 vs. Sham, #P < 0.05,
J. Lu et al. / Neuroscience Letters 573 (2014) 13–18 17
Fig. 4. The effects of exercise on BDNF level and TrkB expression in hippocampus and PFC. Sham operation or bilateral OVX was  performed. After 8 weeks exercise, the
hippocampus and PFC of rats were collected for assay of BDNF level and TrkB expression as described in Section 2. A, BDNF level in hippocampus of Sham and OVX groups with



























orotein  expression in hippocampus of Sham and OVX groups with or without exerc
epresentative protein bands were presented on top of histogram. All data are pre
VX.  R: Pearson’s correlation coefﬁcient.
he coregulators responsible for estrogen actions in hippocampus
nd PFC remain unknown. Moreover, we could not exclude other
ossibilities for the discriminative effect of estrogen on BDNF in dif-
erent brain regions. Such as, duration of estrogen treatment in the
resent study might be not enough to cause signiﬁcant inﬂuence
n BDNF in PFC.
So far, few studies have focused on the effect of exercise on
strogen deﬁciency-induced depression. We  showed that exercise
meliorated depression-like behavior including a decrease in loco-
otor activity and behavioral despair in OVX rats, indicating that
xercise is effective as antidepressant treatment does. However,
he mechanisms underlying exercise improve depression remain
argely unknown. Exercise can increase estrogen level in the periph-
ral circulation of OVX rats [25]. Although we demonstrated that
xercise increased serum E2 level, the serum E2 level only corre-
ated to some behavior parameters such as locomotor activity in
hese rats. Thus, it suggests that serum E2 level may  be associated
ith certain aspects of depression-like behavior. And in addition
o increasing serum E2 level, other mechanisms might also be
nvolved in exercise amelioration of depression. Meeusen [26] has
emonstrated that exercise promotes the secretion of neurotrans-
itters including 5-HT, which may  partly explain the beneﬁcialffect of exercise on depressive symptoms.
Exercise can enhance hippocampal function by increasing the
roduction of BDNF, which is associated with antidepressive effect
f exercise [27]. Consistently, the present study showed that TrkB protein expression in PFC of Sham and OVX groups with or without exercise.
d as means ± SEM (n = 8 in each group). *P < 0.05, **P < 0.01 vs. Sham, ##P < 0.01 vs.
exercise resulted in a signiﬁcant increase in BDNF level in hip-
pocampus. However, we  also found that increased E2 level did not
correlate to BDNF level in hippocampus in the rats with exercise.
It may  suggest that other factors might also be involved in the
stimulatory effect of exercise on BDNF. For example, it has been
shown that exercise can induce hippocampal BDNF by increasing
the expression of ﬁbronectin type III domain-containing protein 5
[28].
In conclusion, OVX induces depression-like behavior and down-
regulates BDNF level in hippocampus. Estrogen replacement and
exercise ameliorate depression-like behavior and reverse BDNF
level in hippocampus. Exercise amelioration of depression is partly
due to increasing E2 level in circulation.
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